Mirum Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Mirum Pharmaceuticals has a total shareholder equity of $248.7M and total debt of $306.4M, which brings its debt-to-equity ratio to 123.2%. Its total assets and total liabilities are $646.6M and $398.0M respectively.
Key information
123.2%
Debt to equity ratio
US$306.42m
Debt
| Interest coverage ratio | n/a |
| Cash | US$286.33m |
| Equity | US$248.67m |
| Total liabilities | US$397.95m |
| Total assets | US$646.62m |
Recent financial health updates
Recent updates
Mirum Pharmaceuticals: Advancing On Several Key Fronts
Mar 05There's Reason For Concern Over Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Price
Dec 26
What Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) P/S Is Not Telling You
Jun 10Industry Analysts Just Made A Captivating Upgrade To Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Revenue Forecasts
Apr 18Mirum's liver disease drug Livmarli gets EMA committee nod for approval in EU
Oct 14Mirum: Great Sales Start For Livmarli Paves The Way For Long-Term Growth
Aug 17Mirum Pharmaceuticals announces $80M stock offering
Aug 09Mirum Pharmaceuticals: Post-Approval Execution Looks Excellent
May 27Is Mirum Pharmaceuticals (NASDAQ:MIRM) In A Good Position To Invest In Growth?
Apr 22Mirum Pharmaceuticals Gets The 'Thumbs Up'
Dec 16Need To Know: Analysts Just Made A Substantial Cut To Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates
Nov 25Mirum And Maralixibat In Pediatric Cholestasis: The Differentiation
Aug 24Analysts Have Made A Financial Statement On Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Second-Quarter Report
Aug 09Financial Position Analysis
Short Term Liabilities: MIRM's short term assets ($387.5M) exceed its short term liabilities ($87.1M).
Long Term Liabilities: MIRM's short term assets ($387.5M) exceed its long term liabilities ($310.9M).
Debt to Equity History and Analysis
Debt Level: MIRM's net debt to equity ratio (8.1%) is considered satisfactory.
Reducing Debt: MIRM's debt to equity ratio has increased from 0% to 123.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MIRM has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if MIRM has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.